Characterizing the Frequency of Pharmacogenomic Biomarker-Guided Prescribing for Drugs with Pharmacogenomic Biomarker information in the FDA Labelling: A Pilot Study Using Data from an Electronic Health Record

Emily Beth Devine, Maher Khelifi, Katelyn Keyloun, Nathaniel Hendrix, Patrick Mathias, Christian Bock, Peter Tarczy-Hornoch. Characterizing the Frequency of Pharmacogenomic Biomarker-Guided Prescribing for Drugs with Pharmacogenomic Biomarker information in the FDA Labelling: A Pilot Study Using Data from an Electronic Health Record. In AMIA 2015, American Medical Informatics Association Annual Symposium, San Francisco, CA, USA, November 14-18, 2015. AMIA, 2015. [doi]

Authors

Emily Beth Devine

This author has not been identified. Look up 'Emily Beth Devine' in Google

Maher Khelifi

This author has not been identified. Look up 'Maher Khelifi' in Google

Katelyn Keyloun

This author has not been identified. Look up 'Katelyn Keyloun' in Google

Nathaniel Hendrix

This author has not been identified. Look up 'Nathaniel Hendrix' in Google

Patrick Mathias

This author has not been identified. Look up 'Patrick Mathias' in Google

Christian Bock

This author has not been identified. Look up 'Christian Bock' in Google

Peter Tarczy-Hornoch

This author has not been identified. Look up 'Peter Tarczy-Hornoch' in Google